Danaher (NYSE:DHR) had its price objective upped by Piper Jaffray Companies from $148.00 to $153.00 in a research report released on Thursday, The Fly reports. They currently have a neutral rating on the conglomerate’s stock. Piper Jaffray Companies also issued estimates for Danaher’s Q2 2019 earnings at $1.19 EPS, Q3 2019 earnings at $1.16 EPS, Q4 2019 earnings at $1.37 EPS, FY2019 earnings at $4.79 EPS, Q2 2020 earnings at $1.38 EPS, Q3 2020 earnings at $1.33 EPS and Q4 2020 earnings at $1.55 EPS.
A number of other research firms also recently weighed in on DHR. Wolfe Research started coverage on Waters in a report on Thursday, May 30th. They set an underperform rating on the stock. Needham & Company LLC reaffirmed a buy rating and set a $150.00 price objective (up from $135.00) on shares of Veeva Systems in a report on Wednesday, April 17th. Janney Montgomery Scott lifted their price objective on Danaher from $136.00 to $174.00 and gave the company a buy rating in a report on Wednesday, April 17th. Finally, Zacks Investment Research downgraded GALP ENERGIA SG/ADR from a hold rating to a sell rating in a report on Monday, May 6th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Danaher presently has a consensus rating of Buy and an average price target of $139.08.
Danaher stock opened at $141.61 on Thursday. The company has a quick ratio of 1.91, a current ratio of 2.32 and a debt-to-equity ratio of 0.33. The business has a 50-day simple moving average of $140.27. The company has a market capitalization of $101.59 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.56 and a beta of 0.96. Danaher has a 52 week low of $94.59 and a 52 week high of $145.50.
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.48%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s payout ratio is currently 15.04%.
In other news, EVP Daniel L. Comas sold 30,000 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $131.00, for a total value of $3,930,000.00. Following the transaction, the executive vice president now directly owns 164,039 shares of the company’s stock, valued at approximately $21,489,109. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Alan G. Spoon sold 1,913 shares of the business’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $129.52, for a total value of $247,771.76. Following the completion of the transaction, the director now directly owns 86,863 shares in the company, valued at $11,250,495.76. The disclosure for this sale can be found here. Insiders sold a total of 453,448 shares of company stock worth $59,724,640 over the last three months. 11.40% of the stock is owned by company insiders.
Several institutional investors and hedge funds have recently made changes to their positions in the company. CX Institutional raised its position in Danaher by 188.7% in the 1st quarter. CX Institutional now owns 205 shares of the conglomerate’s stock worth $27,000 after purchasing an additional 134 shares during the last quarter. Executive Wealth Management LLC bought a new position in Danaher in the 4th quarter worth approximately $39,000. Lenox Wealth Management Inc. bought a new position in Danaher in the 1st quarter worth approximately $40,000. Sontag Advisory LLC bought a new stake in shares of Danaher during the 4th quarter valued at $47,000. Finally, Clarfeld Financial Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at $50,000. 78.86% of the stock is currently owned by institutional investors and hedge funds.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: What is Compound Annual Growth Rate (CAGR)?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.